Fractionated stereotactic radiotherapy of benign skull-base tumors: a dosimetric comparison of volumetric modulated arc therapy with Rapidarc® versus non-coplanar dynamic arcs

被引:2
|
作者
Martin, Fanny [1 ]
Magnier, Florian [2 ]
Berger, Lucie [2 ]
Miroir, Jessica [1 ]
Chautard, Emmanuel [3 ]
Verrelle, Pierre [1 ,3 ]
Lapeyre, Michel [1 ]
Biau, Julian [1 ,3 ]
机构
[1] Ctr Jean Perrin, Dept Radiotherapy, F-63011 Clermont Ferrand, France
[2] Ctr Jean Perrin, Dept Med Phys, F-63011 Clermont Ferrand, France
[3] Clermont Auvergne Univ, CREaT EA7283, F-63011 Clermont Ferrand, France
来源
RADIATION ONCOLOGY | 2016年 / 11卷
关键词
Benign skull base tumors; Fractionated stereotactic radiotherapy; Novalis; Volumetric modulated arc therapy; Dynamic arc therapy; RADIATION-THERAPY; FRAMELESS RADIOSURGERY; CONFORMAL ARC; STATIC-FIELD; HEARING-LOSS; RAPID ARC; SYSTEM; CANCER; BRAIN; DELIVERY;
D O I
10.1186/s13014-016-0632-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Benign tumors of the skull base are a challenge when delivering radiotherapy. An appropriate choice of radiation technique may significantly improve the patient's outcomes. Our study aimed to compare the dosimetric results of fractionated stereotactic radiotherapy between non-coplanar dynamic arcs and coplanar volumetric modulated arctherapy (Rapidarc (R)). Methods: Thirteen patients treated with Novalis TX (R) were analysed: six vestibular schwannomas, four pituitary adenomas and three meningioma. Two treatment plans were created for each case: dynamic arcs (4-5 non coplanar arcs) and Rapidarc (R) (2 coplanar arcs). All tumors were >3 cm and accessible to both techniques. Patients had a stereotactic facemask (Brainlab) and were daily repositioned by Exactrac (R). GTV and CTV were contoured according to tumor type. A 1-mm margin was added to the CTV to obtain PTV. Radiation doses were 52.2-54 Gy, using 1.8 Gy per fraction. Treatment time was faster with Rapidarc (R). Results: The mean PTV V95 % was 98.8 for Rapidarc (R) and 95.9 % for DA (p = 0.09). Homogeneity index was better with Rapidarc (R) : 0.06 vs. 0.09 (p = 0.01). Higher conformity index values were obtained with Rapidarc (R): 75.2 vs. 67.9 % (p = 0.04). The volume of healthy brain that received a high dose (V90 %) was 0.7 % using Rapidarc (R) vs. 1.4 % with dynamic arcs (p = 0.05). Rapidarc (R) and dynamic arcs gave, respectively, a mean D40 % of 10.5 vs. 18.1 Gy (p = 0.005) for the hippocampus and a Dmean of 25.4 vs. 35.3 Gy (p = 0.008) for the ipsilateral cochlea. Low-dose delivery with Rapidarc (R) and dynamic arcs were, respectively, 184 vs. 166 cm(3) for V20 Gy (p = 0.14) and 1265 vs. 1056 cm(3) for V5 Gy (p = 0.67). Conclusions: Fractionated stereotactic radiotherapy using Rapidarc (R) for large benign tumors of the skull base provided target volume coverage that was at least equal to that of dynamics arcs, with better conformity and homogeneity and faster treatment time. Rapidarc (R) also offered better sparing of the ipsilateral cochlea and hippocampus. Low-dose delivery were similar between both techniques.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Dosimetric comparison: volumetric modulated arc therapy and stereotactic body radiotherapy for prostate cancer patients
    Cheung, E. Y. W.
    Chan, G. C. K.
    Ma, R. W. S.
    Nip, E. Y.
    Fong, K.
    Wong, J. S. Y.
    Lam, C. N. K.
    ANNALS OF ONCOLOGY, 2024, 35 : S1328 - S1329
  • [23] Feasibility of MR-only radiation planning for hypofractionated stereotactic radiotherapy of schwannomas using non-coplanar volumetric modulated arc therapy
    Ilamurugu, Arivarasan
    Chandrasekaran, Anu Radha
    Ayyalusamy, Anantharaman
    Shanmugam, Subramanian
    Velayudham, Ramasubramanian
    KattaCharu, Gautham Reddy
    Satpathy, Shyama Prasanna
    RADIOLOGIA MEDICA, 2019, 124 (05): : 400 - 407
  • [24] Feasibility of MR-only radiation planning for hypofractionated stereotactic radiotherapy of schwannomas using non-coplanar volumetric modulated arc therapy
    Arivarasan Ilamurugu
    Anu Radha Chandrasekaran
    Anantharaman Ayyalusamy
    Subramanian Shanmugam
    Ramasubramanian Velayudham
    Gautham Reddy KattaCharu
    Shyama Prasanna Satpathy
    La radiologia medica, 2019, 124 : 400 - 407
  • [25] A comparative dosimetric evaluation of dynamic conformal arc therapy and volumetric modulated arc therapy for lung stereotactic body radiotherapy
    Thanh, Nguyen Van
    Tuong, Pham Nguyen
    Tai, Duong Thanh
    Loan, Truong Thi Hong
    Sandwall, Peter
    Bradley, David
    Chow, James C. L.
    NUCLEAR ENGINEERING AND TECHNOLOGY, 2025, 57 (04)
  • [26] Volumetric-Modulated Arc Radiotherapy for Skull-Base and Non-Skull-Base Head and Neck Cancer: A Treatment Planning Comparison with Fixed Beam IMRT
    Chen, Jianzhou
    Mok, Edward
    Wang, Lilie
    Chen, Chuangzhen
    Quynh-Thu Le
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2013, 12 (01) : 11 - 18
  • [27] Monitoring of mechanical errors and their dosimetric impact throughout the course of non-coplanar continuous volumetric-modulated arc therapy
    Hirashima, Hideaki
    Nakamura, Mitsuhiro
    Miyabe, Yuki
    Uto, Megumi
    Nakamura, Kiyonao
    Mizowaki, Takashi
    RADIATION ONCOLOGY, 2018, 13
  • [28] Monitoring of mechanical errors and their dosimetric impact throughout the course of non-coplanar continuous volumetric-modulated arc therapy
    Hideaki Hirashima
    Mitsuhiro Nakamura
    Yuki Miyabe
    Megumi Uto
    Kiyonao Nakamura
    Takashi Mizowaki
    Radiation Oncology, 13
  • [29] Volumetric Modulated Arc Therapy vs. Conventional Stereotactic Radiotherapy Techniques for Benign Intracranial Tumors
    Subramanian, V.
    Kathirvel, M.
    Swamy, S. Thirumalai
    Arun, G.
    Chilukuri, S.
    Kala, S.
    Jagadeesh, N.
    Subramani, V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S783 - S783
  • [30] A dosimetric comparison of non-coplanar volumetric modulated arc therapy and non-coplanar fixed field intensity modulated radiation therapy in hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for brain metastases
    Zeng, Huaqu
    Zhong, Minzhi
    Chen, Zongyou
    Tang, Shukui
    Wen, Zunbei
    FRONTIERS IN ONCOLOGY, 2025, 14